F 0695
Provide safe and appropriate respiratory care for a resident when needed.
Level of Harm - Minimal harm
or potential for actual harm
Based on observation, interview, and record review, the facility failed to safely store respiratory care therapy
tubing and masks after the therapy.
Residents Affected - Some
This applies to 5 of 5 residents (R27, R65, R67, R81, and R291) reviewed for respiratory equipment in a
sample of 18.
Findings include:
1. On 5/10/2023 at 10:01 AM, R81's nebulizer tubing and mouthpiece were observed uncovered and
undated. The nebulizer tubing and mouthpiece were hanging from her nightstand and touching the floor.
R81's uncovered oxygen tubing was observed on her wheelchair, uncovered and undated.
R81's POS (Physician Order Sheet), dated 4/28/2023, showed an order for oxygen at two liters per minute
to keep oxygen saturation above 92 percent.
On 5/11/2023 at 10:25 AM, V2 (DON-Director of Nursing) stated all oxygen and nebulizer tubing and
mouthpieces should be dated to reflect the date the tubings were changed. She said oxygen and nebulizer
tubings and mouthpieces should be placed in a plastic bag when not in use for infection control. She said
the oxygen and nebulizer tubings and mouthpieces should never be touching the floor.
2. On 5/9/23 at 2:45 PM, R65's oxygen cannula, nebulizer tubing, and mouthpiece were uncovered and
undated.
R65's face sheet shows a diagnosis of dyspnea, emphysema, obstructive sleep apnea, obstructive sleep
apnea, atrial fibrillation, and anxiety. MDS (Minimum Data Set), dated 04/10/2023 shows R65 is cognitively
intact.
A review of R65's Physician Order Sheet, dated 04/22/2023 and 05/03/2023, showed R65 had orders for
oxygen 2 liters per minute per nasal cannula as needed to maintain an oxygen saturation level at 92
percent or above, and an albuterol inhaler three milliliters twice daily and as every four hours as required
respectively.
Notified V3 (Registered Nurse) walking by in the hallway, and V3 said respiratory tubing and masks need to
be stored properly.3. On 5/10/2023 at 9:01 AM, R67's nebulizer tubing and mouthpiece were on top of her
nightstand, uncovered, and undated.
R67's POS (Physician Order Sheet), dated 4/4/2023, shows an order for Ipratropium-Albuterol inhalation
solution 0.5 - 2.5 milligram per 3 milliliters every six hours for shortness of breath. POS,
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 4
Event ID:
146192
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
146192
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/12/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Thrive of Lisle
2850 Ogden Avenue
Lisle, IL 60532
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0695
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
dated 4/10/2023, shows an order for oxygen at two liters per minute per nasal cannula to keep oxygen
saturation above 92 percent. R67's EMR (Electronic Medical Record) showed R67 had a diagnosis of acute
respiratory failure with hypoxia, pneumonia, and pleural effusion.
4. On 5/10/2023 at 9:25 AM, R27's oxygen tubing and nasal cannula was observed hanging on the oxygen
regulator attached to the wall. The tubing and nasal cannula were uncovered and undated.
R27's POS, dated 4/26/2023, shows an order for oxygen at 2 liters per minute per nasal cannula to keep
oxygen saturation above 92 percent.
5. On 5/10/2023 at 10:29 AM, R291's oxygen tubing and nasal cannula was observed uncovered and
undated on his nightstand.
R291's POS, dated 5/5/2023, showed an order for oxygen at two liters per minute per nasal cannula to
maintain oxygen saturation above 92 percent.
Facility's Oxygen/Nebulizer/Bipap/Cpap Tubing Policy dated September 2022 stated . 1. Residents requiring
nebulizer, oxygen and/or CPAP/BIPAP therapy will have tubing stored in a clean container and/or bag when
not in use.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
146192
If continuation sheet
Page 2 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
146192
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/12/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Thrive of Lisle
2850 Ogden Avenue
Lisle, IL 60532
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761
Level of Harm - Minimal harm
or potential for actual harm
Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted
professional principles; and all drugs and biologicals must be stored in locked compartments, separately
locked, compartments for controlled drugs.
Based on observation, interview, and record review, the facility failed to safely store resident medications.
Residents Affected - Few
This applies to 3 of 3 residents (R29, R291, R284) reviewed for medication storage in a sample of 18.
Findings include:
1. R29's Face sheet shows a diagnosis of dementia, and R29's MDS (Minimum Data Set) shows severely
impaired cognition.
R29's POS (Physician Order Sheet) states to apply antifungal powder to groin topically every 12 hours,
9am and 9pm, for rash. R29's Care Plan, dated 4/7/23, shows R29 has impaired safety awareness and staff
should educate the resident and caregivers about safety reminders and anticipate and meet the resident's
needs.
On 5/9/23 at 10:17AM, 5/10/23 at 12:58PM, and 5/11/23 at 12:50PM, Miconazole nitrate 2% antifungal
powder medication was observed in R29's room on his nightstand.
On 5/11/23 at 12:52PM, V5, LPN (Licensed Practical Nurse), said R29 gets the antifungal powder for
redness in his groin, but the medication has to be kept in the medication cart. V5 (LPN) said the medication
should not be left at the bedside because R29 is confused, and might mistake the medication for something
else.
On 5/11/23 at 2:11PM, V2, DON (Director of Nursing), said R29 is absolutely not allowed to have
medications at his bedside. V2 said R29 is cognitively impaired, and R29 could ingest the antifungal
powder, causing harm to himself.
2. On 5/9/2023 at 11:33 AM, a bottle of Acetaminophen 500 mg was observed on R291's nightstand. He
stated that medication was brought in by his daughter on 5/6/2023. The medication did not have resident's
name on it.
On 5/9/2023 at 12:22 PM, V8 (RN-Registered Nurse) stated R291 has no order for Acetaminophen 500
mg, and has no order for self-administration of medication. R291's POS (Physician Order Sheet) on
5/9/2023 at 12:30 PM did not show order for Acetaminophen 500 mg, and no order for Acetaminophen 500
mg to be self-administered and kept at bedside. R291's EMR (Electronic Medical Record) shows diagnosis
of dislocated left shoulder and gout.
3. On 5/10/2023 at 11:20 PM, Fluticasone Furoate Inhalation Powder 200 mcg (micrograms) was observed
on R284's bedside table. She said the nurse left it there after medication was administered.
On 5/10/2023 at 11:25, V7 (RN) said the Fluticasone Furoate Inhalation Powder 200 mcg should be kept in
the medication cart. She stated R284 did not have an order to keep the inhaler by the bedside and had no
order to self-administer the inhaler.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
146192
If continuation sheet
Page 3 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
146192
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/12/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Thrive of Lisle
2850 Ogden Avenue
Lisle, IL 60532
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
R291's POS reviewed, no order for Fluticasone Furoate Inhalation Powder 200 mcg to be kept at bedside.
R284's EMR shows she diagnosis of asthma.
On 5/10/2023 at 9:52 AM, interview with V2 (DON-Director of Nursing) stated all medication had to be
stored in the medication cart or medication room. She stated there is only one resident in the facility with an
order to keep medication by bedside and order to self-administer medication. She said she expects staff to
be aware when family brings in medication from home and to take the medication, inform the physician and
obtain order for the medication.
Facility's Medication at Bedside Policy revised on 5/2023 stated . 2. Physicians must provide an order for
medication to be kept at bedside. Facility's Medication Labeling and Storage Policy dated January 2020 did
not show any information on medication storage.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
146192
If continuation sheet
Page 4 of 4